Feature

Do Health-Related Social Needs Raise Mortality Risk in Cancer Survivors?


 

FROM CANCER

What Are the Limitations and Research Gaps?

The study findings were limited by several factors including the use of self-reports to measure medical financial hardship, food insecurity, and nonmedical financial concerns in the NHIS, the researchers wrote in their discussion. More research with longer follow-up time beyond 1-5 years is needed, wrote Dr. Zheng and colleagues.

Studies also are needed to illustrate how patient navigation can help prevent patients from falling through the cracks with regard to social needs and financial hardships, Mr. Biru told this news organization.

Other areas for research include how addressing social needs affects health outcomes and whether programs designed to address social needs are effective, he said.

“Finally, qualitative research is needed to capture the lived experiences of cancer survivors facing these challenges. This knowledge can inform the development of more patient-centered interventions and policies that effectively address the social determinants of health and improve overall outcomes for all cancer survivors,” Mr. Biru said.

What Is the Takeaway Message for Clinicians?

HRSNs and financial hardship are significantly associated with increased risk of mortality in adult cancer survivors, Dr. Zheng and colleagues concluded. Looking ahead, comprehensive assessment of HRSNs and financial hardship may help clinicians connect patients with relevant services to mitigate the social and financial impacts of cancer, they wrote.

“The takeaway message for oncologists in practice is that addressing [HRSNs] and financial hardship is crucial for providing comprehensive and equitable cancer care,” Mr. Biru said during his interview.

“The impact of social determinants of health on cancer outcomes cannot be ignored, and oncologists play a vital role in identifying and addressing these needs,” he said. Sensitive, discussion-based screenings are needed to identify core needs such as food and transportation, but clinicians also can consider broader social factors and work with a team to connect patients to appropriate resources, he added.

“By recognizing the importance of HRSN screening and taking proactive steps to address these needs, oncologists can contribute to improving health outcomes, reducing healthcare disparities, and providing more equitable cancer care for their patients,” he said.

What Other Guidance Is Available?

“High-quality cancer care requires treating the whole person; measuring and addressing anything in their life that could result in poorer health outcomes is a key component of comprehensive care,” Mr. Biru emphasized.

In September 2023, the National Comprehensive Cancer Network (NCCN) convened a working group cochaired by Mr. Biru that developed recommendations for how oncology practices should routinely measure HRSNs (NCCN.org/social-needs).

“The working group proposed that every cancer patient be assessed for food, transportation access, and financial and housing security at least once a year, and be reassessed at every care transition point as well,” Mr. Biru said. Such screenings should include follow-up to connect patients with services to address any HRSNs they are experiencing, he added.

Lead author Dr. Zheng is employed by the American Cancer Society, which as a nonprofit receives funds from the public through fundraising and contributions, as well as some support from corporations and industry to support its mission programs and services. Mr. Biru had no financial conflicts to disclose.

Pages

Recommended Reading

Is Osimertinib Better Alone or With Chemotherapy in Non–Small Cell Lung Cancer?
MDedge Hematology and Oncology
Can Rectal Cancer Patients Benefit from Deintensification of Treatment?
MDedge Hematology and Oncology
‘We Need to Rethink Our Options’: Lung Cancer Recurrence
MDedge Hematology and Oncology
Few Cancer Survivors Meet ACS Nutrition, Exercise Guidelines
MDedge Hematology and Oncology
Could Aspirin Help Treat Breast Cancer?
MDedge Hematology and Oncology
Routine Breast Cancer Screening Should Start at Age 40: USPSTF
MDedge Hematology and Oncology
Potential Cure for Early BRCA-Mutated Breast Cancer?
MDedge Hematology and Oncology
The Long, Controversial Search for a ‘Cancer Microbiome’
MDedge Hematology and Oncology
MicroRNAs May Predict Pancreatic Cancer Risk Years Before Diagnosis
MDedge Hematology and Oncology
Terminal Cancer: What Matters to Patients and Caregivers
MDedge Hematology and Oncology